BioMark Diagnostics Inc.
BioMark Diagnostics Inc.
Indice CSE:
Devise:
BioMark is a Canadian based company that is developing its advanced stage cancer diagnostic business. BioMark’s cancer diagnostics technology platform leverages "Omics" and machine learning which allows for early cancer detection. BioMark is currently focused on bringing its cancer diagnostic kits and detection solution to commercialization standards and hopes to commence distribution once clinical trials are complete and regulatory acceptance is obtained. For more information please visit the company’s website at www.biomarkdiagnostics.com
BioMark Diagnostics Inc. (BUX)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Information d'entreprise
Addresse
130 - 3851 Shell Road
Richmond, BC V6X 2W2
CanadaTéléphone
604-370-0779Fax
--Courriel
info@biomarkdiagnostics.comURL
http://www.biomarkdiagnostics.comDate d’inscription à la cote
Lundi, novembre 3, 2014
Agent de transfert
Computershare Investor Services Inc.Relations avec les investisseurs
Rashid BuxVérificateur
MNP LLPSEDAR Information
Type de dossier
Tout
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
130 - 3851 Shell Road
Richmond, BC V6X 2W2
CanadaTéléphone
604-370-0779Fax
--Courriel
info@biomarkdiagnostics.comURL
http://www.biomarkdiagnostics.comDate d’inscription à la cote
Lundi, novembre 3, 2014
Agent de transfert
Computershare Investor Services Inc.Relations avec les investisseurs
Rashid BuxVérificateur
MNP LLPCapitalisation
Capitalisation:
105090213Réservé à l'émission:
34112984Communiqués de presse
18/06/2019
BioMark Announces Debt Settlement
